<?xml version="1.0" encoding="iso-8859-1"?><CoCoMacExport xmlns="http://www.cocomac.org" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.cocomac.org http://www.cocomac.org/cocomac.xsd">
<Header>
<Creator>CoCoMac-Online</Creator>
<CoCoMacVersion>20</CoCoMacVersion>
<ExportDate>2013-10-30T15:31:30+01:00</ExportDate>
<DataType>BibliographicData</DataType>
<DataType>BrainMapData</DataType>
<Feedback>
<Query>
<HttpString>Search=LITERATURE&amp;OutputType=XML_BROWSER&amp;SearchString=('MRV00') [LITID]&amp;Details=</HttpString>
<SearchString>('MRV00') [LITID]</SearchString>
<SqlString>SELECT  Top 32767  ID,Literature FROM Literature WHERE  (Literature ='MRV00') </SqlString>
</Query>
<Results>1</Results>
</Feedback>
<Comments>CocoMac XML Output</Comments>
</Header>
<BibliographicData>
<ID>MRV00</ID>
<Authors>
<Author>
<Initials>RJ</Initials>
<LastName>Morecraft</LastName>
</Author>
<Author>
<Initials>KS</Initials>
<LastName>Rockland</LastName>
</Author>
<Author>
<Initials>GW</Initials>
<LastName>Van Hoesen</LastName>
</Author>
</Authors>
<Title>Localization of area prostriata and its projection to the cingulate motor cortex in the rhesus monkey</Title>
<Year>2000</Year>
<Journal>
<JournalName>Cereb. Cortex</JournalName>
<Volume>10</Volume>
<Pages>192-203</Pages>
<PubMedID>10667987</PubMedID>
</Journal>
</BibliographicData>
<MapData>
<BrainMap>
<IDBrainMap>MRV00</IDBrainMap>
<BrainSiteList>
<BrainSite>
<ID_BrainSite>MRV00-23c</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>23c</Acronym>
<FullName>Area 23c</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-24b</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>24b</Acronym>
<FullName>Area 24b</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>24c</Acronym>
<FullName>Area 24c (rostral part of the cingulate sulcus)</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA1</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>CA1</Acronym>
<FullName>CA1 subfield of Ammon`s horn</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA2</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>CA2</Acronym>
<FullName>CA2 subfield of Ammons horn</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA3</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>CA3</Acronym>
<FullName>CA3 subfield of Ammons horn</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA4</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>CA4</Acronym>
<FullName>CA4 subfield of Ammons horn</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-DG</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>DG</Acronym>
<FullName>dentate gyrus</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-EC</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>EC</Acronym>
<FullName>Entorhinal cortex</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-M3</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>M3</Acronym>
<FullName>rostral cingulate motor cortex</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-M4</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>M4</Acronym>
<FullName>caudal cingulate motor cortex</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-OA</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>OA</Acronym>
<FullName>Extrastriate area OA</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>P</Acronym>
<FullName>Area prostriata</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-ParaS</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>ParaS</Acronym>
<FullName>Parasubiculum</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-PEci</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>PEci</Acronym>
<FullName>Caudal part of the cingulate sulcus</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-PreS</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>PreS</Acronym>
<FullName>presubiculum</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-PreS-lpe</ID_BrainSite>
<SiteClass>Lamina_Ctx</SiteClass>
<Acronym>PreS-Lpe</Acronym>
<FullName>Presubiculum-lamina pyramidale externa</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-PreS-lpi</ID_BrainSite>
<SiteClass>Lamina_Ctx</SiteClass>
<Acronym>PreS-Lpi</Acronym>
<FullName>Presubiculum-lamina pyramidale interna</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-ProS</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>ProS</Acronym>
<FullName>Prosubiculum</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-Prostriata</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>Prostriata</Acronym>
<FullName>Area Prostriata</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-RSpC</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>RSpC</Acronym>
<FullName>Retrosplenial cortex</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-Sub</ID_BrainSite>
<SiteClass>Area_AlloCtx</SiteClass>
<Acronym>Sub</Acronym>
<FullName>Subiculum</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V1</Acronym>
<FullName>Visual area 1</FullName>
<DefType>D</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V2</Acronym>
<FullName>Visual area 2</FullName>
<DefType>D</DefType>
</BrainSite>
</BrainSiteList>
</BrainMap>
</MapData>
<ExperimentalData>
<ID_Literature>MRV00</ID_Literature>
<Method>
<TracerSubstance>
<ID_Tracer>TAA</ID_Tracer>
<FullName>Tritiated Amino Acids</FullName>
<Anterograde>true</Anterograde>
<Retrograde>false</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>8-14 d</SurvivalTime>
<Thickness_Sections>?</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>4</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca mulatta</MacaqueSpecies>
<Sex>?</Sex>
<Number>4</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>1,0</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>1,0</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-23c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>1,0</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-23c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>1,0</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
<Method>
<TracerSubstance>
<ID_Tracer>FB</ID_Tracer>
<FullName>Fast Blue</FullName>
<Anterograde>false</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>8-14 d</SurvivalTime>
<Thickness_Sections>?</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>4</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca mulatta</MacaqueSpecies>
<Sex>?</Sex>
<Number>4</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>J</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>F</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>J</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA1</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA2</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA3</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-CA4</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-DG</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-OA</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>M</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-ParaS</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>L</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
<Comments>see figure 2D for this labeling</Comments>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-PreS</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>M</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-ProS</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-RSpC</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>M</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-Sub</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 2</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.2</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>true</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>F</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>3</Degree>
<PDC_Density>G</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-23c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>J</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
<Method>
<TracerSubstance>
<ID_Tracer>BDA</ID_Tracer>
<FullName>Biotinylated dextran amine</FullName>
<Anterograde>true</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>21-28 d</SurvivalTime>
<Thickness_Sections>?</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>3</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca mulatta</MacaqueSpecies>
<Sex>?</Sex>
<Number>3</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>A</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>F</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-23c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>A</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>A</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-OA</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>M</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>T</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>p. 196</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-ParaS</ID_BrainSite>
<SiteType>Area_AlloCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>L</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
<Method>
<TracerSubstance>
<ID_Tracer>DY</ID_Tracer>
<FullName>Diamidino Yellow</FullName>
<Anterograde>false</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>8-14 d</SurvivalTime>
<Thickness_Sections>?</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>2</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca mulatta</MacaqueSpecies>
<Sex>?</Sex>
<Number>2</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-23c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MRV00-24c</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>C</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.2</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-196,Table 1</TextPageNumber>
<FigureNumber>Fig. 1</FigureNumber>
<Quotation>&amp;quot;Injection Site Locations.All injections were confined to cytoarchitectural area 24c (M3) or area 23c (M4) (Fig. 1, Table1). The criteria of Conde (Conde, 1987) was used to assess the fluorescent injection sites (cases 1-4). Zones 0-II correspond to the effective uptake site and zone III its periphery. Injection sites 1, 2A, 2B and 4 have been characteized in former report (Morecraft and Van Hoesen, 1993, 1998). In all cases, the effective injection site was confined to the gray matter of the lower bank of the cingulate sulcus with the exception of case 3A. CAse 3A received a single injection of FB into mid-levels of area 24c. This location corresponded to the arm representation of M3 based upon the heavy labeling found in the arm representation of the primary motor cortex (M1). The solid deposit of the FB injection site (zone I) and zones II and III involved layers I-IV. In the coronal plane, the injection coursed diagonally from medial to lateral across all gray matter layers of the lower bank, ending in the ventral portion of the fundus, including 300 micrometer of subcortical matter. The white matter penetration did not involve the cingulum bundle. Case 3B received a single injection of DY in the caudal one-third of area 24c where zones 0-III were all confined to the gray matter. This location corresponded to the leg representation of M3 based upon the heavy labeling found in the leg representation of M1. In the coronal plane, the injection was located in the middle of the lower bank of the cingulate sulcus. Cases 5 and 6 received multiple injection of tritiatd amino acids in area 24c, whereas cases 7 and 8 received multile injections of the same tracer into areas 23c. In all cases, the isotope was confined to cortex lining the lower bank of the cingulate sulcus. The injection site in case 5 was extensive in the rostrocaudal direction involving most of area 24c. Case 6 involved he caudal one-half of area 24c. The injection site in case 7 involved the rostral two-thirds of area 23c and case 8 the caudal half of this same field. The BDA injections incases 9-11, and their somatotopical affiliation have als been described previously (Morecraft et al., 1996). Briefly, the injection in case 9 involved the face representation of M3 and labeled terminals in the facial nucleus, whereas the injection in case 10 involved the arm representation of M3 and labeled terminals in the brachial spinal cord. The injection in case 11 involved the face and arm representations of M4 and labeled terminals in the facial nucleus and brachial spinal cord.&amp;quot; (pp. 192-193)</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-P</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>F</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>1</Degree>
<PDC_Density>G</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V1</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>MRV00-V2</ID_BrainSite>
<SiteType>Area_IsoCtx_3D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>N</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>0</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>MRV00</ID_Literature>
<TextPageNumber>pp. 195-197</TextPageNumber>
<FigureNumber>-</FigureNumber>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
</ExperimentalData>
</CoCoMacExport>
